September 22, 2026 | ASCO, Congress, Pharma, healthcare, oncology
As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate increasingly complex science in a way that creates meaningful engagement?

The pace of innovation in oncology is accelerating, bringing more data, more complex science, and more information for HCPs to navigate.
Our latest oncology congress eBook explores what this means for life sciences organizations and how congress experiences can help turn scientific innovation into understanding.
Discover insights on:
Making meaningful connections in an age of accelerated innovation
Creating more effective congress experiences
The future of congress engagement for life sciences companies
Emerging trends shaping oncology commercialization
Why a connected approach is key to congress success
This content was provided by Inizio
Latest Content from Inizio
Discover how AI, analytics and real-world data are reshaping Medical Affairs.
Discover how teams from across Inizio provided a range of integrated services to give a client’s product the best chance of launch success.
Explore Inizio Medical’s key takeaway from ISMPP EU 2026, including AI governance, transparency, patient partnership and evolving impact measurement.
At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional collaboration and AI can unlock faster, more actionable insights across medical and…
Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more specific ways – when it…
Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,…
Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.
The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what…
Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.
As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected…
